[Genetic diversity of the mumps viruses (Paramyxoviridae: Orthorubulavirus: Mumps orthorubulavirus): an overview].


Journal

Voprosy virusologii
ISSN: 2411-2097
Titre abrégé: Vopr Virusol
Pays: Russia (Federation)
ID NLM: 0417337

Informations de publication

Date de publication:
05 05 2022
Historique:
received: 05 05 2022
accepted: 05 05 2022
entrez: 6 5 2022
pubmed: 7 5 2022
medline: 10 5 2022
Statut: epublish

Résumé

Mumps is an infectious disease controlled by specific vaccine prophylaxis. To date, its social and epidemiological significance remains high. This is evidenced by the process of developing and implementing into the health care practices of many countries a set of measures for surveillance of mumps. In the Russian Federation, the National Program «Elimination of measles and rubella and achievement of sporadic morbidity with epidemic mumps in the Russian Federation (2021-2025)» and the national plan for its implementation were adopted in 2021. The basis for the adoption of these documents was the development of the domestic trivalent vaccine for the prevention of measles, rubella and mumps, Vaktrivir, and the start of its clinical application. The availability of this vaccine will make the epidemiological surveillance of mumps to be a part of the existing system of appropriate measures for measles and rubella. The fulfillment of this set of tasks involves the study of the molecular epidemiology of the mumps virus (MuV) with possible subsequent implementation of its methodology into the surveillance actions. In this connection, this work was aimed at presenting the data on global genetic diversity of MuV as well as its genotyping methods in a systematized form. The analysis of MuV global genetic diversity in different years will be the starting point in the subsequent development of approach to monitoring virus strains circulating in the Russian Federation.

Identifiants

pubmed: 35521982
doi: 10.36233/0507-4088-98
doi:

Substances chimiques

Measles-Mumps-Rubella Vaccine 0
Mumps Vaccine 0

Types de publication

Journal Article Review

Langues

rus

Sous-ensembles de citation

IM

Pagination

95-106

Auteurs

T S Chekhlyaeva (TS)

FSBI «Gabrichevsky research institute for epidemiology and microbiology» of the Surveillance of Consumer Rights Protection and Human Welfare (Rospotrebnadzor).

D V Erokhov (DV)

FSBI «Gabrichevsky research institute for epidemiology and microbiology» of the Surveillance of Consumer Rights Protection and Human Welfare (Rospotrebnadzor).

I Yu Andrievskaya (IY)

FSBI «Gabrichevsky research institute for epidemiology and microbiology» of the Surveillance of Consumer Rights Protection and Human Welfare (Rospotrebnadzor).

P E Zherdeva (PE)

FSBI «Gabrichevsky research institute for epidemiology and microbiology» of the Surveillance of Consumer Rights Protection and Human Welfare (Rospotrebnadzor).

N T Tikhonova (NT)

FSBI «Gabrichevsky research institute for epidemiology and microbiology» of the Surveillance of Consumer Rights Protection and Human Welfare (Rospotrebnadzor).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH